Клинический случай малосимптомного течения «амиодаронового легкого»

1. Singh VK, Maheshwari V. Acute respiratory distress syndrome complicated by amiodarone induced pulmonary fibrosis: Don’t let your guard down. J Clin Diagn Res. 2017;11(4):UD01–UD02.

PMID: 28571241. PMCID: PMC5449887. https://doi.org/10.7860/JCDR/2017/24710.9674

2. Hamilton D Sr, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C et al. Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs. 2020;20(6):549–58.

PMID: 32166725. https://doi.org/10.1007/s40256-020-00401-5

3. Feduska ET, Thoma BN, Torjman MC, Goldhammer JE. Acute amiodarone pulmonary toxicity. J Cardiothorac Vasc Anesth. 2021;35(5):1485–94.

PMID: 33262034. https://doi.org/10.1053/j.jvca.2020.10.060

4. Motawea A, Ahmed DAM, El-Mansy AA, Saleh NM. Crucial role of PLGA nanoparticles in mitigating the amiodarone-induced pulmonary toxicity. Int J Nanomedicine. 2021;16:4713–37.

PMID: 34267519. PMCID: PMC8276877. https://doi.org/10.2147/IJN.S314074

5. Водоевич В.П., Виноградова Т.А., Заяц А.Н., Козеева Ж.В., Лакотко Т.Г., Харук Ю.Е. с соавт. Случай поражения легких амиодароном. Лечебное дело: научно-практический терапевтический журнал. 2020;(1):54–58. (Vodoevich VP, Vinogradova TA, Zayats AN, Kozeeva ZhV, Lakotko TG, Kharuk YuE et al. A case of lung damage by amiodarone. Lechebnoe delo: nauchno-prakticheskiy terapevticheskiy zhurnal = General Medicine: Scientific and Practical Therapeutic Journal. 2020;(1):54–58 (In Russ.)). EDN: QDFLQC.

6. Трофименко И.Н., Черняк Б.А. «Амиодароновое» легкое: обзор литературы и собственные наблюдения. Фарматека. 2018;(3):26–33. (Trofimenko IN, Chernyak BA. “Amiodaron lung”: Literature review and own observations. Farmateka. 2018;(3):26–33 (In Russ.)). EDN: YRSGHZ.

7. Takla A, Eid F, Ukrani H, Mohamed M, Lee E. Amiodarone-induced lung toxicity: An underrecognized and fatal presentation. Adv Clin Med Res Healthc Deliv. 2024;4(2).

https://doi.org/10.53785/2769-2779.1215

8. Kanagaki S, Suezawa T, Moriguchi K, Nakao K, Toyomoto M, Yamamoto Y et al. Hydroxypropyl cyclodextrin improves amiodarone-induced aberrant lipid homeostasis of alveolar cells. Am J Respir Cell Mol Biol. 2021;64(4):504–14.

PMID: 33493427. https://doi.org/10.1165/rcmb.2020-0119OC

9. Jackevicius CA, Tom A, Essebag V, Eisenberg MJ, Rahme E, Tu JV et al. Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol. 2011;108(5):705–10.

PMID: 21704281. https://doi.org/10.1016/j.amjcard.2011.04.024

10. Mitrofan CE, Cretu A, Mitrofan C, Bar C, Ghiciuc CM. Amiodarone induced lung disease. Arch Clin Cases. 2022;9(3):126–32.

PMID: 36176494. PMCID: PMC9512125. https://doi.org/10.22551/2022.36.0903.10217

11. Baumann H, Fichtenkamm P, Schneider T, Biscoping J, Henrich M. Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection – a case report and review of recent literature. Ann Med Surg (Lond). 2017;21:53–57.

PMID: 28794867. PMCID: PMC5537372. https://doi.org/10.1016/j.amsu.2017.07.034

12. Горбунов А.А., Миронов С.Е., Кудряшов Н.В., Лемина Е.Ю. Лекарственно-индуцированные поражения органов дыхания. Экспериментальная и клиническая фармакология. 2023;86(2):42–52. (Gorbunov AA, Mironov SE, Kudryashov NV, Lemina EYu. Drug-induced respiratory damage. Eksperimental’naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology. 2023;86(2):42–52 (In Russ.)).

EDN: WRENDV. https://doi.org/10.30906/0869-2092-2023-86-2-42-52

13. Мартьянова Л.И., Харитонова Г.В., Доброхотова Е.Н., Капитан А.В., Кулагина С.В., Усьманкина Т.А. Случаи рентгенологической диагностики амиодаронового поражения легких. Здравоохранение Чувашии. 2020;(3):65–73. (Martyanova LI, Kharitonova GV, Dobrokhotova EN, Captain AV, Kulagina SV, Usmankina TA. Cases of radiological diagnosis of amiodarone pulmonary lesion. Zdravoohranenie Chuvashii = Healthcare in Chuvashia. 2020;(3):65–73 (In Russ.)).

EDN: GCUFWP. https://doi.org/10.25589/GIDUV.2020.92.31.021

14. Bui A, Han S, Alexander M, Toner G, Irving L, Manser R. Pulmonary function testing for the early detection of drug-induced lung disease: A systematic review in adults treated with drugs associated with pulmonary toxicity. Intern Med J. 2020;50(11):1311–25.

PMID: 31588628. https://doi.org/10.1111/imj.14647

15. Анаев Э.Х. Лекарственно-индуцированное интерстициальное заболевание легких: подходы к диагностике и лечению. Терапевтический архив. 2020;92(3):84–91. (Anaev EKh. Drug-induced interstitial lung disease: approaches to diagnostics and treatment. Terapevticheskiy arkhiv = Therapeutic Archive. 2020;92(3):84–91 (In Russ.)).

EDN: KGLYSC. https://doi.org/10.26442/00403660.2020.03.000399